Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

3 Dividend Stocks That Are No-Brainer Buys Right Now


There are well over 5,000 stocks on the market that pay dividends. It would take you years to analyze each one of them in detail. Fortunately, you don't have to exert such an effort.

Three Fool.com contributors have identified dividend stocks that they think are no-brainers to buy right now. Here's why they picked (NYSE: ABBV), Eli Lilly (NYSE: LLY), and Gilead Sciences (NASDAQ: GILD).

Keith Speights (AbbVie): AbbVie's top-selling drug Humira has lost its U.S. patent exclusivity. Longtime CEO Rick Gonzalez is passing the baton to Rob Michael, who currently serves as the company's president and COO. In more ways than one, it's a new stage for the big drugmaker. But I think it will be a good one.

Continue reading


Source Fool.com

AbbVie Inc. Stock

€172.72
2.930%
There is an upward development for AbbVie Inc. compared to yesterday, with an increase of €4.92 (2.930%).
With 32 Buy predictions and not a single Sell prediction AbbVie Inc. is an absolute favorite of our community.
With a target price of 180 € there is a slightly positive potential of 4.21% for AbbVie Inc. compared to the current price of 172.72 €.
Like: 0
Share

Comments